Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Ab&B Bio-Tech CO., LTD. JS Class H
2627Health technology
$2B
Market Cap
Shariah Analysis
TBD
Business
Cash
Liabilities
Based on AAOIFI screening standards, Ab&B Bio-Tech CO., LTD. JS Class H appears to be TBD.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)0.00%
Non-Shariah Cash Items
Cash And Cash Equivalents$132.2M
Restricted Cash$138K
Liabilities (<30%)0.00%
Non-Shariah Liabilities
Current Capital Lease Obligation$7.1M
Long Term Debt$462M
Long Term Capital Lease Obligation$42.1M
Current Debt$347.5M
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
